Recombinant human porphobilinogen deaminase (Porphozym) ( DrugBank: Porphobilinogen )


1 disease
IDDisease name (Link within this page)Number of trials
254Porphyria1

254. Porphyria


Clinical trials : 70 Drugs : 54 - (DrugBank : 19) / Drug target genes : 19 - Drug target pathways : 35
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00418795
(ClinicalTrials.gov)
June 11, 20034/1/2007Porphozym in the Treatment of Acute Attacks in AIPA Multi-centre, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial, Investigating the Efficacy and Safety of Porphozym (Recombinant Human Porphobilinogen Deaminase) in the Treatment of Acute Attacks in AIPAcute Intermittent PorphyriaDrug: recombinant human porphobilinogen deaminase (Porphozym)Zymenex A/SNULLCompleted18 YearsN/AAll36Phase 2/Phase 3United States